SSc-PAH is associated with elevated metalloproteinase inhibitors, including TIMP-4 levels, indicating a cardiopulmonary vasculature-specific role of TIMP-4 activation in SSc [116,117,118,119]. The gene discussed is TIMP4; the disease is pulmonary arterial hypertension.